PDIA3 and neuroblastoma: Furthermore, it has been shown that short-term Aβ25-35 treatment of human neuroblastoma cells induces PDIA3 decreases in intracellular protein levels, different intracellular localization, and PDIA3 secretion in the cultured medium [39].